1st Quarter - Report

NATIONAL VENTURE CAPITAL ASSOCIATION for NATIONAL VENTURE CAPITAL ASSOCIATION

Firm
Client
Income
—
Expenses
$221,006
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

8 issue areas, each in the filer's own words, with who lobbied on it and where.

Medical/Disease Research/Clinical Labs MED

S1734/HR2182 Gain Act - support incentives for antibiotic development; S2113 Treat Act; HR 4132 - FAST Act - support expanding accelerated approval pathway

LobbyistCovered position, as disclosed
EMILY BAKER —
JENNIFER DOWLING —
MARK HEESEN —
KELLY SLONE —

Contacted: HOUSE OF REPRESENTATIVES; Patent & Trademark Office (PTO); Securities & Exchange Commission (SEC); White House Office; Treasury, Dept of; Office of the Vice President of the United States; Food & Drug Administration (FDA); SENATE; Centers For Medicare and Medicaid Services (CMS)

Bills named: H.R. 4132 (112th), H.R. 2182 (112th)

Telecommunications TEC

S 2105Cybersecurity Act of 2012; HR 4263/S2151 - Secure IT Act of 2012; Bills to protect critical infrastructure against cyber based espionage and IP theft, and terror attacks. Privacy and information sharing issues

LobbyistCovered position, as disclosed
EMILY BAKER —
JENNIFER DOWLING —
MARK HEESEN —
KELLY SLONE —

Contacted: Food & Drug Administration (FDA); Office of the Vice President of the United States; Patent & Trademark Office (PTO); SENATE; Securities & Exchange Commission (SEC); Treasury, Dept of; White House Office; Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES

Bills named: H.R. 4263 (112th)

Health Issues HCR

S17 Medical Device Access and Innovation Protection Act HR 436 Protect Medical Innovation Act of 2011 - lobbied to repeal the medical device tax act on small medical device companies

LobbyistCovered position, as disclosed
EMILY BAKER —
JENNIFER DOWLING —
MARK HEESEN —
KELLY SLONE —

Contacted: Centers For Medicare and Medicaid Services (CMS); Office of the Vice President of the United States; SENATE; Food & Drug Administration (FDA); White House Office; Securities & Exchange Commission (SEC); Patent & Trademark Office (PTO); Treasury, Dept of; HOUSE OF REPRESENTATIVES

Bills named: H.R. 436 (112th)

Banking BAN

S 1933/Hr 3606 The Reopening American Capital Markets to Emerging Growth Companies Act of 2011: Support the entire bill

LobbyistCovered position, as disclosed
EMILY BAKER —
JENNIFER DOWLING —
MARK HEESEN —
KELLY SLONE —

Contacted: Food & Drug Administration (FDA); SENATE; Treasury, Dept of; HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); Patent & Trademark Office (PTO); White House Office; Office of the Vice President of the United States; Securities & Exchange Commission (SEC)

Bills named: H.R. 3606 (112th)

Taxation/Internal Revenue Code TAX

Taxation of carried interest; capital gains tax policy

LobbyistCovered position, as disclosed
EMILY BAKER —
JENNIFER DOWLING —
MARK HEESEN —
KELLY SLONE —

Contacted: Treasury, Dept of; Food & Drug Administration (FDA); Securities & Exchange Commission (SEC); Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; Office of the Vice President of the United States; White House Office; SENATE; Patent & Trademark Office (PTO)

Copyright/Patent/Trademark CPT

S23/HR1249 The America Invests Act of 2011. Lobbied on provisions dealing with post grant application procedures; first to file; and how these investments would impact small business investment and job growth.

LobbyistCovered position, as disclosed
EMILY BAKER —
JENNIFER DOWLING —
MARK HEESEN —
KELLY SLONE —

Contacted: SENATE; Patent & Trademark Office (PTO); Food & Drug Administration (FDA); Office of the Vice President of the United States; Centers For Medicare and Medicaid Services (CMS); Treasury, Dept of; White House Office; Securities & Exchange Commission (SEC); HOUSE OF REPRESENTATIVES

Bills named: H.R. 1249 (112th)

Energy/Nuclear ENG

Renewable energy policy issues: Loan guarantee program and clean energy deployment administration budget issues for FY2012. Continuing resolution: budget issues for FY2012 Energy and Water; ARPA-E funding. Clean Energy Standard Act of 2012(CESA)

LobbyistCovered position, as disclosed
EMILY BAKER —
JENNIFER DOWLING —
MARK HEESEN —
KELLY SLONE —

Contacted: White House Office; HOUSE OF REPRESENTATIVES; Securities & Exchange Commission (SEC); Treasury, Dept of; SENATE; Centers For Medicare and Medicaid Services (CMS); Office of the Vice President of the United States; Food & Drug Administration (FDA); Patent & Trademark Office (PTO)

Immigration IMM

Specific lobbying issue: Support for EB6-The Start Up Visa Act allowing foreign born entrepreneurs who receive venture capital and create US jobs to remain in the country; HR 3692 Invest Act

LobbyistCovered position, as disclosed
EMILY BAKER —
JENNIFER DOWLING —
MARK HEESEN —
KELLY SLONE —

Contacted: Securities & Exchange Commission (SEC); Office of the Vice President of the United States; White House Office; Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; SENATE; Treasury, Dept of; Patent & Trademark Office (PTO); Food & Drug Administration (FDA)

Bills named: H.R. 3692 (112th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.